A B S T R A C T The metabolism of thyroxine (T4) was studied in slices of rat pituitary gland and liver from the same animal incubated in vitro with ['25I]T4 and 10 mM dithiothreitol. In the pituitary gland, generation of '251-labeled 3,5,3'-triiodothyronine (T3), as well as overall T4 degradation, increased significantly at 24 h after thyroidectomy and by 2 wk were approximately five times control values. Conversely, following a single injection of T3 (1.5 j.g/100 g body wt), values for both functions were significantly decreased at 4 h, and reached a nadir of '20% of control values at 12 and 24 h. Net T3-neogenesis accounted for -70% of T4 degradation in control pituitaries from intact rats. This proportion was increased by thyroidectomy and decreased by T3 replacement. Indirect evidence indicated that thyroidectomy decreased, and T3 administration increased, non-T3 generating pathways of T4 metabolism, probably 5-monodeiodination leading to formation of 3,3'5'-triiodothyronine (rT3). As judged from studies by others, the prompt changes in T4 metabolism that followed thyroidectomy or T3 administration could not be explained by changes in pituitary cell type. Changes in T3-neogenesis in liver were the converse of those in pituitary, and were much slower to occur.
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In the thyroidectomized rat, administration of cycloheximide resulted in an -60% inhibition of pituitary T3-neogenesis and T4-degradation at 4 h, a timecourse of inhibition similar to that produced by T3. Unlike T3, cycloheximide did not alter the proportion of T4 degradation that could be accounted for by T3 neogenesis, and appeared, therefore, to inhibit both T3 generating and non-T3 generating pathways. The time-course of the inhibitory effect of cycloheximide Presented in part at the 62nd Annual Meeting of the En- docrine Society, Washington, D. C., 18-20 June 1980. Received for publication 9 February 1981 and in revised form 17 December 1981. on the incorporation of [3H]leucine into hemipituitaries in vitro was parallel to its effect on T3-neogenesis. The inhibition of T3-neogenesis that occurred when T3 and cycloheximide were given together did not exceed the effect of T3 alone, suggesting a common mechanism of action of the two agents.
From the foregoing information, the following tentative conclusions are drawn: (a) turnover of the 5'-monodeiodinase for T4 in rat pituitary is rapid, substantially more so than in liver; (b) thyroidectomy enhances, and T3 inhibits, the conversion of T4 to T3 in the pituitary; these manipulations have opposite effects on the non-T3 generating pathways of T4 metabolism, probably the 5-monodeiodination of T4 that produces rT3; (c) these changes are probably the result of parallel effects on the synthesis of the corresponding enzymes; (d) the changes in T3-neogenesis described may permit an intrapituitary feedback mechanism that damps the changes in TSH secretion mediated by classical feedback regulatory control; (e) the effects of hypothyroidism and T3-replacement on T3-neogenesis and overall T4 degradation in liver were opposite to those produced in the pituitary. Hence, among differing tissues, the same stimuli may produce greatly INTRODUCTION Recent reports have emphasized the importance of 3,5,3'-triiodothyronine (T3)1 generated locally from thyroxine (T4) within the pituitary in the regulation of TSH secretion (1) (2) (3) . This would imply the existence of a critical interaction between the thyroid secretion of T4 and the pituitary conversion of T4 to T3 (T3-neogenesis) in the regulation of thyroid function.
Because of the potential importance of this relationship, we undertook studies of pituitary T3-neogenesis, using the rat pituitary as an in vitro model. Bisected, rather than homogenized, pituitaries were mainly used in order to maintain conditions as near physiological as possible. We also compared the properties of the T3-generating systems in the pituitary with those in the liver, the organ in which T3-neogenesis has been most extensively studied. Two types of control vessels were employed in each experiment. One contained tissue slices or homogenates, but was incubated for 0 min (zero-time control); the other contained no tissue and was incubated for 3 h at 370C (tissuefree control).
METHODS
Analysis of reaction products. After methanol-ammonia had been added, reaction mixtures were analyzed by paper chromatography. 10 Statistical analyses. The statistical significance of differences between the results obtained in various experimental groups was assessed by means of the t test when experiments involved only two groups and analysis of variance followed by the Newman-Keuls test when results in more than two groups were being compared among one another (7).
RESULTS
In many of the experiments, the time-course of the effect of a particular experimental manipulation was assessed. In experiments of this type, pituitaries from both control and experimental animals were studied at each time point. Because Once again, in this experiment, the pattern of T4 metabolism and the effect thereon of exogenous T3 were quite different in liver. After T3 treatment, the liver responded more slowly than the pituitary, and in an opposite direction (Fig. 3) . Hepatic T3 neogenesis in the hypothyroid rats was unchanged at 4 h, when pituitary T3-neogenesis had already decreased to half of the initial values. T3-neogenesis in liver was increased significantly (P < 0.01) at 24 h, and was still greater at 48 h, when activity in the pituitary had already returned to control values.
Changes in other aspects of hepatic T4 metabolism induced by T3 were again the converse of those induced by thyroidectomy (Table I) . At 48 h, overall T4 degradation, the fraction of T4 degradation accounted for by T3 generation, and excess iodide generation had all increased significantly. Effect of T3 in vitro. The effect of T3 added in vitro on T3-neogenesis in the pituitary of the thyroidectomized rat was also studied. Paired hemipituitaries from hypothyroid rats were incubated for 3 h in media to which either no T3 or concentrations of T3 ranging between 10 and 800 ng/ml had been added. These changes in the extracellular T3 concentration had no apparent effect on T3-neogenesis or on other aspects of ['25I]T4 metabolism (data not shown).
Effect of T4 in vivo. To determine whether exogenous T4, like T3, would decrease pituitary T3-neogenesis in vitro, rats thyroidectomized 2 wk earlier were given a single injection of T4 (10 Ag/lOO g body wt, s.c.). Pituitaries were obtained 3.5 h later and their metabolism of [251I]T4 compared with that of pituitaries from untreated controls. T4 administration induced a profound decrease in the rate of T3-neogenesis, values decreasing from 12.7±0.5 to 1.3±0.2% of added ['25j]T4/ mg protein (P < 0.01). T4 degradation was also decreased by the administration of T4, from 25.8±0.9 to 4.9±0.4% of added [1251I]T4/mg protein (P < 0.01). Changes induced by T4 in the derived values for various aspects of T4 metabolism were similar to those that followed the administration of T3.
Effect of cycloheximide. Because of its very prompt onset, we wondered whether the inhibition of T3-neoThyroid Status and Pituitary Thyroxine Metabolism genesis induced by T3 in the pituitary of the hypothyroid rat could be due to inhibition of the synthesis of the 5'-monodeiodinase for T4. As a consequence, we undertook studies of the effects of the inhibitor of protein synthesis, cycloheximide. Thyroidectomized rats were given a single injection of cycloheximide (1.0 ,ug/g body wt s.c.), a dose twice that shown in previous studies to inhibit greatly the in vivo incorporation of amino acids into protein in multiple tissues and to be negligibly toxic (8) . Control rats received saline alone. Rats were killed at 2, 4, 6, and 20 h following the administration of cycloheximide, and the time-course of changes in pituitary T3-neogenesis were studied. Values were expressed as a percentage of those in simultaneously studied untreated controls.
Cycloheximide had no significant effect on the pituitary protein/wet weight ratio. It did, however, produce a prompt, though transient, inhibition of pituitary T3-neogenesis. Values were reduced significantly (P < 0.05) to 36.0±5.8% of those seen in control pituitaries at 4 h (Table I) , but values had returned to near normal (90% of control) in pituitaries obtained 6 h after administration of cycloheximide and thereafter (Fig. 4) In pituitaries obtained at that time, generation of T3 from T4 was inhibited both by cycloheximide and by T3, and to about the same extent. When the two agents were given together, however, no evidence that their effects were additive could be obtained (Fig. 5) . Almost identical results were obtained in two additional experiments in which the combined and separate effects of T3 and cycloheximide were studied.
Effects of cycloheximide on amino acid incorporation. To examine the correlation between the effects of cycloheximide on T3-neogenesis and its effects on protein synthesis, the experiments with cycloheximide described above were repeated, in part, except that pituitaries were incubated with [3H]leucine rather than ['25I]T4. Rats thyroidectomized 2 wk earlier were given a single injection of cycloheximide (1.0 ,g/g body wt s.c.) and were killed 4 or 6 h later; controls received saline alone. Bisected pituitaries were then incubated individually for 3 h at 370C in room air in a medium of Krebs-Ringer phosphate, pH 7.4, containing [3H]leucine (1 ,uCi/ml). At the end of the incubations, pituitaries were homogenized in their own medium. Aliquots were treated with an equal volume of 12% cold TCA. After the resulting precipitates had been washed with 6% TCA they were transferred to scintillation vials containing Toluene-Triton X-100 counting fluid and their content of 3H was measured. A separate aliquot of each homogenate was added directly to the counting fluid so that total 3H counts in each incubation vessel could be determined. Per- 
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In control pituitaries (n = 7), incorporation of [3H]leucine averaged 14.8±1.2% of the total. In pituitaries from animals killed 4 h after cycloheximide (n = 5), values decreased significantly (P < 0.01) to 7.2±0.4%. A return toward control values was observed in the pituitaries of animals given cycloheximide 6 h before death (n = 5) The mean of 10.6±0.5% in this group was significantly greater (P < 0.01) than values in the pituitaries of 4-h animals, but significantly less than the mean values in controls (P < 0.01).
Degradation of T3 and rT3. During 3-h incubations, only a very small proportion (1-2%) of ['25I]T3 was degraded by pituitary homogenates or slices, and this was true in tissues obtained from both thyroidectomized rats and comparable rats treated with T3 (Table II) . In contrast, metabolism of rT3 was exceedingly rapid, somewhat more so in homogenates than in slices, and was not influenced by the thyroid status of the animal.
DISCUSSION
The present studies have served to clarify several properties of the enzymatic mechanisms by which T4 undergoes metabolism in the rat pituitary, at least as judged from the results of incubations of ['25I]T4 with hemipituitaries. The major findings of these studies relate to the activity of the 5'-monodeiodinase that converts T4 to T3 (and by inference the 5-monodeiodinase that converts T4 to rT3), and to the rapidity and direction of changes in the activity of this enzyme that follow alterations in the thyroid hormone status of the animal.
In earlier studies, Cheron and associates (9) and Kaplan (10) have examined the effects of chronic alterations in thyroid hormone status on the metabolism of T4 by pituitary slices or homogenates, respectively. Hypothyroidism of 2-3-mo duration was shown to be associated with enhanced conversion of T4 to T3. Conversely, formation of T3 from T4 was depressed in animals made thyrotoxic by the administration of T4 (10 jig/100 g body wt) daily for 5 d. Our findings complement these observations by demonstrating that alterations in the rate of T3 formation from T4 do not require chronic changes in thyroid hormone status, but occur with extreme rapidity. Thus, in vitro T3-neogenesis by hemipituitaries was more than doubled by 24 h after thyroidectomy. Conversely, when a single, relatively small, dose of T3 (1.5 ,ug/100 g body wt) was
given to thyroidectomized animals, in vitro T3-neogenesis by hemipituitaries was significantly decreased by 4 h, and was greatly reduced by 24 h. Addition of T3 to incubation media, even in high concentrations, did not cause a similar inhibition of T3-neogenesis; however, this may have been due to an insufficient period of exposure to T3 (3 h) or to insufficient penetration of the added T3 into the pituitary cells. Several tentative conclusions can be drawn concerning the mechanism whereby these rapid effects of in vivo T3 on pituitary T4 metabolism were brought about. With the small quantities of pituitary tissue available for study, the rate of metabolism of T4 was very limited in the absence of cofactor. Consequently, all studies were conducted in the presence of DTT, an agent that stabilizes reduced sulfhydryl groups and is thought to uncover thereby the maximum activity of the deiodinating enzymes (11) . This would suggest that the changes in T3-generating activity that we observed were the result of alterations in enzyme activity per se, rather than changes in the availability of sulfhydryl cofactors.
It is possible that some of the changes in overall T4 metabolism and in T3-neogenesis that we observed were the result of variations in the rate of tissue uptake of T4 under the various conditions of study, rather than the result of differences in the rate and pathways of intracellular T4 metabolism. Operation of this mechanism cannot be entirely excluded, since tissue uptake of T4 was not studied. Nonetheless, it cannot account for all of the changes observed, since the alterations in the rate and direction of T4 metabolism induced by varying thyroid states, as reported here for hemipituitaries, were also observed by us (data not shown) and others (10) in pituitary homogenates.
The second conclusion relates to the possible role of changes in pituitary cell type on the patterns of T4 metabolism observed. Kaplan has suggested that the 5'-monodeiodinating activity of thyrotrophs might exceed that of other pituitary cells, and that an increase in the proportion of thyrotrophs would explain, therefore, the increased T3-neogenesis seen in the pituitary of the hypothyroid rat (10) . One might then infer that the decreased 5'-monodeiodination of T4, as seen in pituitaries of thyrotoxic rats by previous workers (9, 10) , is the result of a decrease in the proportion of thyrotrophs. Our findings, considered in relation to the data of De Fesi et al. (12) , suggest that this is not the case. Their studies revealed that the percentage of thyrotropin (TSH) cells in the rat pituitary is increased only slightly by 5 d after thyroidectomy (from 7.5 to 9.8% of the total), whereas we find that Ts-neogenesis is doubled by 24 h after thyroidectomy and is four times that in control pituitaries by 7 d. Conversely, in the same studies (12) , the percentage of TSH-cells in the pituitaries of thyroidectomized rats was not reduced by 2 d of treatment with T3, 10 ,g/100 g body wt daily. In contrast, we found the generation of T3 from T4 to be reduced to '50% of control levels at 4 h, and to 20% of control levels at 24 h, after only one injection of 1. The nature of the non-T3 generating pathway for T4 metabolism in rat pituitary whose activity varies directly with thyroid hormone status is not clearly proven. We have been unable to detect a pathway for the oxidative cleavage of the ether-link of the T4 molecule with loss of outer ring iodine (15) , since no labeled iodotyrosines were detected after incubation of hemipituitaries with biosynthetically derived, uniformly labeled T4. On the otherhand, we have demonstrated generation of ['25I]rT3 from ['25I]T4 during short term (15 min) incubations. Our inability to detect
[15I]rT3 after long term incubations is likely due to rapid degradation of the ['25I]rT3, since studies in pituitary homogenates revealed that exogenous ['25I]rT3 was deiodinated with great rapidity. We would suggest, therefore, that the pathway of T4 metabolism in rat pituitary whose activity is decreased by thyroid hormone insufficiency and increased by hormone replacement is the 5-monodeiodination of T4 that leads to the formation of rT3.
It seems clear from the present findings that there exists within the pituitary itself a feedback mechanism that regulates T3-neogenesis, in which increased pituitary T3 (and perhaps T4) inhibits further local T3-neogenesis, while decreases in T3 and T4 produce the opposite effects. This mechanism should interact with classical feedback control of TSH secretion, which is negatively correlated with intrapituitary T3 concentration (1-3). Thus, as decreased quantities of T3 and T4 were available to the pituitary, generation of T3 from T4 would become more efficient, and this would tend to limit the increase in TSH secretion that would otherwise occur. Opposite consequences would follow an increase in the availability of T4 and T3 to the TSHsecreting cell. In this light, the feedback mechanism for the regulation of intrapituitary T3-neogenesis would serve to minimize any oscillations in TSH secretion that result from classical regulatory control.
A final aspect of the present findings is the manner in which the effects of thyroidectomy and of T3 administration to the hypothyroid rat differed in the pituitary and liver. One major difference was in the rate at which changes in the pattern of T4 metabolism emerged following changes in thyroid status, those in the pituitary occurring much more promptly than those in the liver. Major qualitative differences were also observed. In confirmation of earlier findings (16) (17) (18) (19) (20) , hypothyroidism decreased, and T3 administration restored to normal, both T4 degradation and T3-neogenesis in liver, effects opposite to those in the pituitary. These findings highlight what may prove to be an extremely important aspect of peripheral T4 metabolism, i.e., the extent to which patterns of thyroid hormone metabolism differ among various tissues, both under normal circumstances and in response to various stimuli.
